Analysts have been steadily raising their estimates for Aadi Bioscience. Over the past three months, the Zacks Consensus Estimate for the company has increased 40.1%. Unlike the overly optimistic Wall ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Aadi Bioscience, Inc, a biopharmaceutical company, engages in developing and ...

Scott M. Giacobello, the CHIEF FINANCIAL OFFICER of $AADI, sold 2,806 shares of the company on 03-03-2025 for an estimated $6,594. We received data on the trade from ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Aadi Koozh is said to be one of the dishes that help our bodies stay cool during the hot summer months. Let’s take a look at ...

MORRISTOWN, N.J., March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to ...

Analysts have been steadily raising their estimates for Aadi Bioscience. Over the past three months, the Zacks Consensus Estimate for the company has increased 40.1%. Unlike the overly optimistic ...

Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer treatment ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...